Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Author(s) -
Sunil Badve,
David J. Dabbs,
Stuart J. Schnitt,
Frederick L. Baehner,
Thomas Decker,
Vincenzo Eusebi,
Stephen B. Fox,
Shu Ichihara,
Jocelyne Jacquemier,
Sunil R. Lakhani,
José Palacios,
Emad A. Rakha,
Andrea L. Richardson,
Fernando Schmitt,
PuayHoon Tan,
Gary M. Tse,
Britta Weigelt,
Ian O. Ellis,
Jorge S. ReisFilho
Publication year - 2010
Publication title -
modern pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 153
eISSN - 1530-0285
pISSN - 0893-3952
DOI - 10.1038/modpathol.2010.200
Subject(s) - medicine , pathology , triple negative , basal (medicine) , triple negative breast cancer , breast cancer , cancer , insulin
Breast cancer is a heterogeneous disease encompassing a variety of entities with distinct morphological features and clinical behaviors. Although morphology is often associated with the pattern of molecular aberrations in breast cancers, it is also clear that tumors of the same histological type show remarkably different clinical behavior. This is particularly true for 'basal-like cancer', which is an entity defined using gene expression analysis. The purpose of this article was to review the current state of knowledge of basal-like breast cancers, to discuss the relationship between basal-like and triple-negative breast cancers, and to clarify practical implications of these diagnoses for pathologists and oncologists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom